Guided Therapeutics (GTHP) Current Deferred Tax Assets (2016)

Historic Current Deferred Tax Assets for Guided Therapeutics (GTHP) over the last 5 years, with Q4 2016 value amounting to $795000.0.

  • Guided Therapeutics' Current Deferred Tax Assets rose 2699.68% to $795000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $795000.0, marking a year-over-year increase of 2699.68%. This contributed to the annual value of $795000.0 for FY2016, which is 2699.68% up from last year.
  • Latest data reveals that Guided Therapeutics reported Current Deferred Tax Assets of $795000.0 as of Q4 2016, which was up 2699.68% from $626000.0 recorded in Q4 2015.
  • In the past 5 years, Guided Therapeutics' Current Deferred Tax Assets ranged from a high of $795000.0 in Q4 2016 and a low of $277000.0 during Q4 2012
  • For the 5-year period, Guided Therapeutics' Current Deferred Tax Assets averaged around $490200.0, with its median value being $466000.0 (2014).
  • Per our database at Business Quant, Guided Therapeutics' Current Deferred Tax Assets surged by 361.01% in 2013 and then soared by 6236.93% in 2014.
  • Guided Therapeutics' Current Deferred Tax Assets (Quarter) stood at $277000.0 in 2012, then increased by 3.61% to $287000.0 in 2013, then soared by 62.37% to $466000.0 in 2014, then soared by 34.33% to $626000.0 in 2015, then grew by 27.0% to $795000.0 in 2016.
  • Its Current Deferred Tax Assets was $795000.0 in Q4 2016, compared to $626000.0 in Q4 2015 and $466000.0 in Q4 2014.